AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 6811379
Drug: Levonorgestrel 250
RxNorm normalized name: ethinyl estradiol 30 MCG / levonorgestrel 250 MG Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Levonorgestrel 250 μg combined with 20 μg ethinyl estradiol
Trial: 28459717
Drug: Negative pressure
RxNorm normalized name: DRESSING,NEGATIVE PRESSURE WOUND
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Negative pressure wound therapy (NPWT) via a novel negative pressure device
Trial: 25425219
Drug: L-RISK diet
RxNorm normalized name: L-377202
DrugBank: L-377202 (DB19022)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-RISK diet (high in cereal fibre: 30-50 g/day and coffee: ≥ 5 cups/day, free of red meat)
Trial: 25425219
Drug: H-RISK diet
RxNorm normalized name: phentermine hydrochloride Oral Capsule [T-Diet]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: H-RISK diet (low in fibre: ≤ 10 g/day, coffee-free, high in red meat: ≥ 150 g/day)
Trial: 24676435
Drug: Treadmill exercise
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Treadmill exercise (30 minutes, twice a week, moderate intensity of 60% VO₂max)
Trial: 8799520
Drug: Oral strontium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral strontium chloride administration under fasting conditions (study I)
Trial: 8799520
Drug: Oral strontium
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral strontium chloride administration with a standardized meal (study II)
Trial: 31202812
Drug: Daily intake
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily intake of vinegar
Trial: 27341068
Drug: Progressive resistance
RxNorm normalized name: ethanol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Progressive resistance and balance exercise program (twice weekly for three months)
Trial: 24124331
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 0 kcal/min
Trial: 24124331
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 0.5 kcal/min
Trial: 24124331
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 1.0 kcal/min
Trial: 24124331
Drug: Intraduodenal glucose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Intraduodenal glucose infusion at 1.5 kcal/min
Trial: 11701674
Drug: High dose
RxNorm normalized name: INFLUENZA VACCINE HIGH DOSE 0.5ML SYR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High dose of GH (0.05 mg/kg x d)
Trial: 11701674
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose of GH (0.025 mg/kg x d)
Trial: 9156352
Drug: SC-52458 (200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC-52458 (200 mg)
Trial: 9156352
Drug: SC-52458 (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC-52458 (100 mg or more)
Trial: 9156352
Drug: SC-52458 (10-150
FDA approved: no
EMA approved: no
PMDA approved: no
Description: SC-52458 (10-150 mg)
Trial: 8251893
Drug: IFN +
RxNorm normalized name: IFNγ
DrugBank: Interferon Gamma (DB15753)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IFN + low-dose Ara-C
Trial: 3102779
Drug: Metoclopramide, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metoclopramide, 10 mg parenterally
Trial: 28449228
Drug: AZA steady
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZA steady (2-2.5 mg/kg/day)
Trial: 28449228
Drug: AZA down
RxNorm normalized name: Kool-Down
FDA approved: no
EMA approved: no
PMDA approved: no
Description: AZA down (1-1.25 mg/kg/day)
Trial: 21484416
Drug: Serotonin reuptake
RxNorm normalized name: Selective serotonin reuptake inhibitors
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Serotonin reuptake inhibitor (SRI) medication
Trial: 15214181
Drug: Normobaric hypoxitherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Normobaric hypoxitherapy (NHT) combined with standard treatment in the basic group of 32 patients.
Trial: 15214181
Drug: Standard treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard treatment only in the control group of 20 patients.
Trial: 8695078
Drug: PCINA for
RxNorm normalized name: Cina artemisia preparation
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PCINA for 4 hours followed by 5 hours of ward‐provided pain therapy (Group 1; n = 10)
Trial: 8695078
Drug: Ward‐provided pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ward‐provided pain therapy for 5 hours followed by 4 hours of PCINA (Group 2; n = 10)
Trial: 8695078
Drug: Ward‐provided pain
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ward‐provided pain therapy
Trial: 6369524
Drug: High-dose methylprednisolone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose methylprednisolone (3.5 mg/kg/day)
Trial: 6369524
Drug: Low-dose methylprednisolone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose methylprednisolone (1.0 mg/kg/day)
Trial: 30269963
Drug: Capacitive resistive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Capacitive resistive monopolar radiofrequency (CRMRF) treatment
Trial: 30269963
Drug: Sham-CRMRF treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Sham-CRMRF treatment
Trial: 26695724
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron (100 mg), folic acid (500 mcg) and placebo for 26 weeks (Group A)
Trial: 26695724
Drug: Weekly iron
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Weekly iron (100 mg), folic acid (500 mcg) and cyanocobalamin (500 mcg for 6 weeks and 15 mcg for 20 weeks) for 26 weeks (Group B)
Trial: 23761326
Drug: 400 IU
RxNorm normalized name: Vitamin D 400 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 400 IU of vitamin D3 daily
Trial: 23761326
Drug: 800 IU
RxNorm normalized name: Vitamin E 800 IU Oral Tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 800 IU of vitamin D3 daily
Trial: 23761326
Drug: 1600 IU
RxNorm normalized name: Ascorbic Acid/Biotin/Calcium/Cholecalciferol/Cyanocobalamin/Folic Acid/Iodine/Niacin/Pantothenic Acid/Pyridoxine/Riboflavin/Thiamine/Vitamin A/Vitamin E/Zinc 40 MG-150 MCG-80 MG-600 IU-3 MCG-100 MCG-70 MCG-6 MG-2.5 MG-0.7 MG-0.8 MG-0.7 MG-1600 IU-10 IU-1.6 MG Oral Tablet, Chewable
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1600 IU of vitamin D3 daily
Trial: 23761326
Drug: 2400 IU
RxNorm normalized name: lipase 2400 UNT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 2400 IU of vitamin D3 daily
Trial: 20163197
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (ERN) 2 g + laropiprant (LRPT) 40 mg
Trial: 20163197
Drug: Extended-release niacin
RxNorm normalized name: niacin Extended Release Oral Capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Extended-release niacin (ERN) 2 g
Trial: 11848169
Drug: Guanabenz (GB;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guanabenz (GB; 2-8 mg at 11 PM, n = 17)
Trial: 10448876
Drug: Cranial radiation
RxNorm normalized name: geranial
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cranial radiation (two doses)
Trial: 8543717
Drug: Brief prevention
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Brief prevention program (BP) consisting of 4 sessions of cognitive-behavioral therapy (CBT)
Trial: 2337214
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic solution prewarmed to 37 degrees C
Trial: 2337214
Drug: Local anaesthetic
RxNorm normalized name: Local anaesthetic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Local anaesthetic solution at room temperature
Trial: 463893
Drug: Abrupt discontinuation
RxNorm normalized name: guaifenesin / hydrocodone bitartrate / phenylephrine hydrochloride Oral Solution [Entex HC Discontinued]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Abrupt discontinuation of lidocaine infusion (Group 1)
Trial: 463893
Drug: Gradual tapering
RxNorm normalized name: mitapivat
DrugBank: Mitapivat (DB16236)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Gradual tapering of lidocaine infusion over a three-hour period (Group 2)
Trial: 463893
Drug: Lidocaine infusion
RxNorm normalized name: Lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Lidocaine infusion for 36 hours or less
Trial: 463893
Drug: Comparison of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Comparison of abrupt cessation versus three-hour tapering of lidocaine infusion
Trial: 31721601
Drug: Inactivated varicella-zoster
RxNorm normalized name: varicella/zoster immunoglobulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Inactivated varicella-zoster virus (VZV) vaccine (ZVIN)
Trial: 30935872
Drug: Closed-loop insulin
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Closed-loop insulin delivery with faster-acting insulin aspart
Trial: 30935872
Drug: Conventional subcutaneous
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Conventional subcutaneous insulin therapy (control group)
Trial: 28611343
Drug: PEG IFN
RxNorm normalized name: PEG IFN-beta-1a
DrugBank: Peginterferon beta-1a (DB09122)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: PEG IFN 180 mcg weekly for 12 months (add-on therapy)
Trial: 28611343
Drug: Tenofovir 300
RxNorm normalized name: tenofovir 300 mg oral tablet
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tenofovir 300 mg orally daily (monotherapy)
Trial: 21317934
Drug: Oral azithromycin
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Oral azithromycin 250 mg daily for 12 weeks
Trial: 12735919
Drug: Experimental formulations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Experimental formulations of low calorie carbonated orange drinks
Trial: 11549101
Drug: 14C-cholesterol-labeled AmBisome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 14C-cholesterol-labeled AmBisome (2 mg/kg, 1 microgCi/kg)
Trial: 7879710
Drug: Whole herpes
RxNorm normalized name: Betula lenta whole
DrugBank: Betula lenta whole (DB14164)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Whole herpes simplex vaccines
Trial: 2849775
Drug: Fentanyl 0.1
RxNorm normalized name: fentanyl 0.1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.1 mg/70 kg
Trial: 2849775
Drug: Fentanyl 0.2
RxNorm normalized name: fentanyl 0.2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.2 mg/70 kg
Trial: 2849775
Drug: Fentanyl 0.25
RxNorm normalized name: bupivacaine-fentanyl 0.25%-20 mcg/mL-0.9% injectable solution
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fentanyl 0.25 mg/70 kg
Trial: 603271
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin (5000 units two hours before operation and 5000 units every 12 hours following operation for five days)
Trial: 603271
Drug: Low dose
RxNorm normalized name: Low Dose ASA
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low dose heparin postoperatively only
Trial: 31655314
Drug: Combined therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combined therapy (exercise followed by massage)
Trial: 23786558
Drug: Continuous ketamine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Continuous ketamine (0.2 mg/kg/hour)
Trial: 12638394
Drug: Vardenafil 20
RxNorm normalized name: vardenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 20 mg after overnight fast
Trial: 12638394
Drug: Vardenafil 20
RxNorm normalized name: vardenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 20 mg after high-fat breakfast
Trial: 12638394
Drug: Vardenafil 20
RxNorm normalized name: vardenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 20 mg on empty stomach in the evening
Trial: 12638394
Drug: Vardenafil 20
RxNorm normalized name: vardenafil 20 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vardenafil 20 mg after moderate-fat meal in the evening
Trial: 10879639
Drug: Azithromycin (500
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Azithromycin (500 mg bid on the 1st day, followed by 500 mg once daily for the next 4 days)
Trial: 10879639
Drug: Doxycycline (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Doxycycline (100 mg bid for 14 days)
Trial: 1378136
Drug: Carvedilol (25
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carvedilol (25 mg b.i.d.)
Trial: 1378136
Drug: Propranolol-ISDN (80
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Propranolol-ISDN (80 mg/20 mg b.i.d.)
Trial: 28555251
Drug: Milk protein
RxNorm normalized name: Milk protein
DrugBank: Casein (DB10516)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Milk protein supplement (SUPP)
Trial: 26086284
Drug: Translaryngeal injection
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Translaryngeal injection (TLI) technique
Trial: 21584955
Drug: Alflutop (intramuscular
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Alflutop (intramuscular injections) + peloid applications
Trial: 10878147
Drug: Time‐averaged daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Time‐averaged daily calcium intake (500 to 1500 mg/day)
Trial: 8410764
Drug: Prototype filament
RxNorm normalized name: Yucca filamentosa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prototype filament suspension design toothbrush (active suspension)
Trial: 8410764
Drug: Prototype filament
RxNorm normalized name: Yucca filamentosa extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Prototype filament suspension design toothbrush (inactive suspension)
Trial: 3516668
Drug: Cognitive‐Behavior Therapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive‐Behavior Therapy
Trial: 28275117
Drug: Parsatuzumab (400
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Parsatuzumab (400 mg) in combination with mFOLFOX6 plus bevacizumab (5 mg/kg)
Trial: 28275117
Drug: Placebo in
RxNorm normalized name: placebo INTRAVEN VIAL (ML)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo in combination with mFOLFOX6 plus bevacizumab (5 mg/kg)
Trial: 18222671
Drug: Aescin and
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aescin and troxerutin combination treatment
Trial: 12725561
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose of SHR-5 Rhodiola rosea extract (2 capsules)
Trial: 12725561
Drug: Higher dose
RxNorm normalized name: BENZOCAINE 50 mg in 1 mL TOPICAL GEL [HIGHER CONTROL Male Climax Control Lubricating]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Higher dose of SHR-5 Rhodiola rosea extract (3 capsules)
Trial: 11089761
Drug: Nebulized ET(A)
RxNorm normalized name: Hydra-Neb
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulized ET(A) receptor antagonist (LU‐135252, 3 mg/kg, inhaled over 1 h)
Trial: 11089761
Drug: Nebulization of
RxNorm normalized name: OIL OF CAMPHOR
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nebulization of saline (5-10 ml inhaled over 1 h)
Trial: 8093824
Drug: All treatments
RxNorm normalized name: All Clear
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: All treatments (Zuclopenthixol acetate, Haloperidol, Zuclopenthixol)
Trial: 3690045
Drug: High sodium
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High sodium intake (16 to 20 g)
Trial: 29513635
Drug: Strip-type bleaching
RxNorm normalized name: collagen type I
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Strip-type bleaching agent
Trial: 29513635
Drug: Paint-on-type bleaching
RxNorm normalized name: Castellani Paint
DrugBank: Phenol (DB03255)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Paint-on-type bleaching agent
Trial: 29513635
Drug: All treatment
RxNorm normalized name: UNDECYLENIC ACID 8 g in 30 mL / TOLNAFTATE 1 g in 30 mL TOPICAL LIQUID [Fugal nall treatment]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: All treatment groups (strip, paint-on, and controls)
Trial: 20543751
Drug: Isomaltulose (ISO),
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Isomaltulose (ISO), 75 g, GI = 32
Trial: 17138192
Drug: IA morphine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: IA morphine 5 mg
Trial: 18505564
Drug: Antidepressants (specific
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressants (specific agents not mentioned)
Trial: 10848717
Drug: Phase II
RxNorm normalized name: Coxiella burnetii phase II Ab
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Phase II and III clinical trial programme (specific agents not mentioned)
Trial: 7758059
Drug: Diclofenac dispersible
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Diclofenac dispersible 50 mg three times daily for 3 to 7 days
Trial: 2204776
Drug: Methyldopa (250
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Methyldopa (250 mg b.i.d.)
Trial: 2204776
Drug: Urapidil (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Urapidil (30 mg b.i.d.)
Trial: 386697
Drug: Proglumide (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proglumide (1200 mg/day)
Trial: 386697
Drug: Magnesium trisilicate
RxNorm normalized name: Magnesium Trisilicate
DrugBank: Magnesium trisilicate (DB09281)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Magnesium trisilicate (1320 mg/day)
Trial: 386697
Drug: Proglumide (1200
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Proglumide (1200 mg/day) and Magnesium trisilicate (1320 mg/day)
Trial: 27925466
Drug: Low-concentration iodinated
RxNorm normalized name: methyl salicylate
DrugBank: Methyl salicylate (DB09543)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Low-concentration iodinated contrast agent (270 mgI/ml) and low tube current (120 mA)
Trial: 27925466
Drug: Standard dose
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Standard dose protocol (370 mgI/ml) and conventional tube current (160 mA)
Trial: 21143588
Drug: Usual care
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Usual care (oral information only)
Trial: 16433875
Drug: ACIDFORM gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACIDFORM gel (5 g, intravaginally once daily for five consecutive days)
Trial: 16433875
Drug: Metronidazole gel
RxNorm normalized name: Metronidazole
DrugBank: Metronidazole (DB00916)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Metronidazole gel (10%, intravaginally once daily for five consecutive days)
Trial: 16433875
Drug: ACIDFORM gel
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ACIDFORM gel
Trial: 14506625
Drug: recombinant human
RxNorm normalized name: Recombinant human TNF
DrugBank: Etanercept (DB00005)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: recombinant human IGF-I (15 microg/kg body weight/d twice daily)
Trial: 10981173
Drug: Low-dose spironolactone
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose spironolactone
Trial: 10981173
Drug: Selective aldosterone
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Selective aldosterone antagonists
Trial: 31987323
Drug: 80 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 80 mg/kg VE
Trial: 25080462
Drug: Low-dose recombinant
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose recombinant human growth hormone (rhGH) (0.05 mg · kg⁻¹ · d⁻¹)
Trial: 22722511
Drug: Oxygen-enriched air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen-enriched air inhalation (normobaric hyperoxia of 40% fraction of inspired oxygen)
Trial: 22722511
Drug: Regular air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular air inhalation (21% fraction of inspired oxygen)
Trial: 22722511
Drug: Oxygen-enriched air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxygen-enriched air inhalation
Trial: 22722511
Drug: Regular air
RxNorm normalized name: air
DrugBank: Medical air (DB09337)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Regular air inhalation
Trial: 20398563
Drug: L-carnitine (5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-carnitine (5 g/d intravenously for seven days)
Trial: 18779465
Drug: DM-specific personal
RxNorm normalized name: Dextromethorphan
DrugBank: Dextromethorphan (DB00514)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: DM-specific personal health record (PHR) that imported clinical and medications data, provided patient-tailored decision support, and enabled the patient to author a 'Diabetes Care Plan' for electronic submission to their physician.
Trial: 15625373
Drug: Carboplatin-paclitaxel combination
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin-paclitaxel combination
Trial: 15625373
Drug: Combination chemotherapy
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination chemotherapy in performance status 2 patients
Trial: 1450310
Drug: Saline (0.1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline (0.1 cc/kg) administered to Group 1 (G1) patients 3 minutes prior to intubation
Trial: 1450310
Drug: Lidocaine (1
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lidocaine (1 mg/kg) administered to Group 2 (G2) patients 3 minutes prior to intubation
Trial: 27214664
Drug: Dipraglurant (50
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipraglurant (50 mg once daily)
Trial: 27214664
Drug: Dipraglurant (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dipraglurant (100 mg 3 times daily)
Trial: 26037427
Drug: Protocol-based standard
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Protocol-based standard therapy (ST)
Trial: 22786751
Drug: Zibotentan 10
RxNorm normalized name: Zibotentan
DrugBank: Zibotentan (DB06629)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Zibotentan 10 mg/day
Trial: 18678157
Drug: Valpromide (medication
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Valpromide (medication group)